Cardiometrics FloWire predicts higher risk of post-PTCA events -- study.
This article was originally published in The Gray Sheet
Executive SummaryCARDIOMETRICS FLOWIRE PREDICTS HIGHER RISK OF MAJOR REPEAT EVENTS at six months post-angioplasty, Patrick Serruys, MD, Erasmus University, Rotterdam, The Netherlands, reported Nov. 14 at the American Heart Association scientific sessions in Anaheim, California. Patients assessed by the Cardiometrics doppler guidewire as having low coronary flow reserve (CFR) following angioplasty had approximately 50% greater chance of suffering a major event, he said.
You may also be interested in...
Moderate growth at Bristol-Myers Squibb and Amgen moved the two companies into the top 10 pharma ranks, based on the most recent Scrip 100 rankings, while declining growth at Gilead and Teva moved those drug makers out.
Momenta Pharmaceuticals has agreed to pay $35.0m to settle claims that it manipulated generic approval processes in the US to shut competitor Amphastar out of the US enoxaparin market.